AI assistant
ARES CAPITAL CORP — Capital/Financing Update 2021
Feb 11, 2021
30427_rns_2021-02-11_4cfde962-9d02-4716-8ffa-9c7394619a81.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
497AD 1 a21-6172_4497ad.htm 497AD
Filed pursuant to Rule 497(a)
Registration No. 333-248831
Rule 482a
Ares Capital Corporation
13,500,000 Shares of Common Stock
| Issuer: | Ares Capital Corporation |
|---|---|
| Symbol / Listing: | ARCC / NASDAQ |
| Base shares offered: | 13,500,000 shares (100% primary) |
| Option to purchase additional shares: | 2,025,000 shares (100% primary) |
| Price per share to the public: | $18.12 |
| Trade date: | February 11, 2021 |
| Closing date: | February 16, 2021 |
| CUSIP No.: | 04010L103 |
| Active Bookrunners: | BofA Securities, Inc. |
| Morgan Stanley & Co. LLC | |
| Wells Fargo Securities, LLC |
Investors are advised to carefully consider the investment objective, risks, charges and expenses of Ares Capital before investing. The preliminary prospectus supplement dated February 10, 2021, together with an accompanying prospectus dated September 16, 2020, which have been filed with the Securities and Exchange Commission, contain this and other information about Ares Capital and should be read carefully before investing.
The information in the preliminary prospectus supplement and the accompanying prospectus, and in this announcement, is not complete and may be changed. The preliminary prospectus supplement, the accompanying prospectus and this announcement are not offers to sell any securities of Ares Capital and are not soliciting an offer to buy such securities in any jurisdiction where such offer and sale is not permitted.
A shelf registration statement relating to these securities is on file with and has been declared effective by the Securities and Exchange Commission. The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus.
SEQ.=1,FOLIO='',FILE='C:\jms\109503\21-6172-4\task10176040\6172-4-bg.htm',USER='109503',CD='Feb 11 22:34 2021'
Copies of the preliminary prospectus supplement (and accompanying prospectus) may be obtained from BofA Securities, Inc., NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department, or by calling 1-800-294-1322, or email [email protected]; Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus Department; or Wells Fargo Securities, LLC at 500 West 33rd Street, New York, New York, 10001, Attn: Equity Syndicate Department, by calling toll free 1-800-326-5897, or by e-mail at [email protected].
ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR AFTER THIS MESSAGE ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.
SEQ.=1,FOLIO='',FILE='C:\jms\109503\21-6172-4\task10176040\6172-4-bg.htm',USER='109503',CD='Feb 11 22:34 2021'